Initially, two conventional cytocidal chemotherapeutic agents for treating oral cancer, namely 5-FU and CDDP, were assessed, but the expression of CXCR4 mRNA was not altered with these treatments. This evidence concerns the gene CXCR4 and lip and oral cavity carcinoma.